JP2001500486A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2001500486A5 JP2001500486A5 JP1998511906A JP51190698A JP2001500486A5 JP 2001500486 A5 JP2001500486 A5 JP 2001500486A5 JP 1998511906 A JP1998511906 A JP 1998511906A JP 51190698 A JP51190698 A JP 51190698A JP 2001500486 A5 JP2001500486 A5 JP 2001500486A5
- Authority
- JP
- Japan
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US2477296P | 1996-08-28 | 1996-08-28 | |
| US60/024,772 | 1996-08-28 | ||
| PCT/US1997/015155 WO1998008546A2 (en) | 1996-08-28 | 1997-08-28 | Therapeutic combinations of rar antagonists and rxr agonists and use thereof |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2001500486A JP2001500486A (ja) | 2001-01-16 |
| JP2001500486A5 true JP2001500486A5 (enExample) | 2005-04-07 |
Family
ID=21822317
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP10511906A Ceased JP2001500486A (ja) | 1996-08-28 | 1997-08-28 | Ｒａｒアンタゴニストとｒｘｒアゴニストとの治療学的組合せおよびその使用 |
Country Status (11)
| Country | Link |
|---|---|
| US (2) | US6130230A (enExample) |
| EP (1) | EP0928200B1 (enExample) |
| JP (1) | JP2001500486A (enExample) |
| AT (1) | ATE236654T1 (enExample) |
| AU (1) | AU731060B2 (enExample) |
| CA (1) | CA2263817A1 (enExample) |
| DE (1) | DE69720745T2 (enExample) |
| ES (1) | ES2196361T3 (enExample) |
| IL (1) | IL128723A0 (enExample) |
| NO (1) | NO990912L (enExample) |
| WO (1) | WO1998008546A2 (enExample) |
Families Citing this family (30)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| BR9914465A (pt) | 1998-09-29 | 2001-10-09 | Gamida Cell Ltd | Métodos para controlar a proliferação e a diferenciação de células-tronco e células progenitoras e uma composição farmacêutica para induzir a diferenciação em uma população de células |
| CA2254429A1 (en) * | 1998-11-19 | 2000-05-19 | Tully Michael Underhill | Compositions for promoting chondrogenesis |
| AU4228000A (en) * | 1999-04-14 | 2000-11-14 | Allergan Sales, Inc. | Methods and compositions for the treatment and prevention of lung disease |
| US6436993B1 (en) * | 1999-07-13 | 2002-08-20 | The Salk Institute For Biological Studies | Use of RAR antagonists as modulators of hormone mediated processes |
| AU784377B2 (en) * | 2000-03-14 | 2006-03-23 | Arthur V. Sampaio | Compositions and methods for affecting osteogenesis |
| AU4866201A (en) * | 2000-04-13 | 2001-10-30 | Pierre Chambon | Compositions and methods for use in modulating immune system function |
| CA2410480A1 (en) | 2000-05-26 | 2001-12-06 | Board Of Trustees Of The University Of Illinois | Reagents and methods for identifying and modulating expression of genes regulated by retinoids |
| WO2002022113A2 (en) | 2000-09-13 | 2002-03-21 | Bristol-Myers Squibb Company | Retinoic acid receptor antagonists as promoters of angiogenesis |
| JP2005500027A (ja) * | 2001-06-11 | 2005-01-06 | ルードヴィッヒ インスティテュート フォー キャンサー リサーチ | ドーパミン分泌細胞の生存を増加させる方法 |
| IL152904A0 (en) * | 2002-01-24 | 2003-06-24 | Gamida Cell Ltd | Utilization of retinoid and vitamin d receptor antagonists for expansion of renewable stem cell populations |
| WO2003062404A1 (en) | 2002-01-25 | 2003-07-31 | Gamida-Cell Ltd. | Methods of expanding stem and progenitor cells and expanded cell populations obtained thereby |
| US20040097587A1 (en) * | 2002-03-27 | 2004-05-20 | Arbiser Jack L | Compositions and methods of treatment of ulcerating diseases, burns, and related conditions |
| JP4473491B2 (ja) * | 2002-05-28 | 2010-06-02 | 株式会社資生堂 | 毛穴縮小剤 |
| US20050054731A1 (en) * | 2003-09-08 | 2005-03-10 | Franco Folli | Multi-system therapy for diabetes, the metabolic syndrome and obesity |
| US20050112123A1 (en) * | 2003-10-06 | 2005-05-26 | Vaughan Michael R. | Methods of treating proteinuria |
| GB2411115A (en) * | 2004-02-19 | 2005-08-24 | Medical Res Council | Retinoic acid antagonists for the treatment of oesophageal disorders |
| WO2006030442A2 (en) | 2004-09-16 | 2006-03-23 | Gamida-Cell Ltd. | Methods of ex vivo progenitor and stem cell expansion by co-culture with mesenchymal cells |
| US8846393B2 (en) | 2005-11-29 | 2014-09-30 | Gamida-Cell Ltd. | Methods of improving stem cell homing and engraftment |
| EP2181710A1 (en) * | 2008-10-28 | 2010-05-05 | Phenex Pharmaceuticals AG | Ligands for modulation of orphan receptor-gamma (NR1F3) activity |
| EP2329817A1 (en) * | 2009-09-04 | 2011-06-08 | Ernst-Moritz-Arndt-Universität Greifswald | Retinoic acid receptor antagonists, miR-10a inhibitors and inhibitors of HOXB1 or HOXB3 repressors for treating pancreatic cancer |
| EP2723347B1 (en) | 2011-06-24 | 2019-09-04 | GRI Bio, Inc. | Prevention and treatment of inflammatory conditions |
| JP6348848B2 (ja) | 2012-02-13 | 2018-06-27 | ガミダ セル リミテッド | 間葉系幹細胞の増殖 |
| US9567569B2 (en) | 2012-07-23 | 2017-02-14 | Gamida Cell Ltd. | Methods of culturing and expanding mesenchymal stem cells |
| US9175266B2 (en) | 2012-07-23 | 2015-11-03 | Gamida Cell Ltd. | Enhancement of natural killer (NK) cell proliferation and activity |
| WO2015026990A2 (en) | 2013-08-20 | 2015-02-26 | University Of Washington Through Its Center For Commercialization | Novel and specific inhibitors of cytochrome p450 26 retinoic acid hydrolase |
| PL3380086T3 (pl) | 2015-11-25 | 2022-02-21 | Io Therapeutics, Inc. | Oporne na cyp26 agonisty selektywne względem rar-alfa w leczeniu nowotworu |
| WO2017214575A1 (en) * | 2016-06-10 | 2017-12-14 | Io Therapeutics, Inc. | Receptor selective retinoid and rexinoid compounds and immune modulators for cancer immunotherapy |
| WO2019014492A1 (en) | 2017-07-13 | 2019-01-17 | Io Therapeutics, Inc. | RETINOID COMPOUNDS AND IMMUNOMODULATORY REXINOIDS IN COMBINATION WITH IMMUNE MODULATORS FOR IMMUNOTHERAPY OF CANCER |
| KR20200044889A (ko) | 2017-08-31 | 2020-04-29 | 아이오 테라퓨틱스, 인크. | 암 면역요법을 위해 면역 조절제와 조합된 rar 선택적 작용제 |
| US12115140B2 (en) * | 2020-07-31 | 2024-10-15 | The Trustees Of Columbia University In The City Of New York | Method of treating adenoid cystic carcinoma |
Family Cites Families (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0575528A4 (en) | 1991-03-18 | 1994-09-14 | Salk Inst For Biological Studi | Response element compositions and assays employing same |
| US5780676A (en) * | 1992-04-22 | 1998-07-14 | Ligand Pharmaceuticals Incorporated | Compounds having selective activity for Retinoid X Receptors, and means for modulation of processes mediated by Retinoid X Receptors |
| US5399586A (en) * | 1993-03-11 | 1995-03-21 | Allergan, Inc. | Treatment of mammals afflicted with tumors with compounds having RXR retinoid receptor agonist activity |
| CA2140354A1 (en) * | 1993-05-18 | 1994-11-24 | Pierre Chambon | Genetically engineered mice containing alterations in the genes encoding retinoic acid receptor proteins |
| US5702914A (en) * | 1994-12-21 | 1997-12-30 | The Salk Institute For Biological Studies | Use of reporter genes for retinoid receptor screening assays having novel retinoid-associated response elements |
| AU4530496A (en) | 1995-01-13 | 1996-07-31 | Salk Institute For Biological Studies, The | Allosteric control of nuclear hormone receptors |
| US5747661A (en) * | 1995-01-13 | 1998-05-05 | Howard Hughes Medical Institute | Retinoid-inducible response elements |
| US5559248A (en) * | 1995-04-05 | 1996-09-24 | Bristol-Myers Squibb Co. | Retinoid-like heterocycles |
| US6025388A (en) * | 1995-04-26 | 2000-02-15 | Allergan Sales, Inc. | Method for inhibiting gene expression promoted by AP1 protein with RARβ selective retinoids and method for treatment of diseases and conditions with such retinoids |
| US5906920A (en) | 1995-08-29 | 1999-05-25 | The Salk Institute For Biological Studies | Methods for the detection of ligands for retinoid X receptors |
| US6586455B1 (en) | 1996-12-31 | 2003-07-01 | The Salk Institute For Biological Studies | Treatment of liposarcomas using a combination of thiazolidinediones and retinoid X receptor selective agonists |
| JP2001507706A (ja) | 1996-12-31 | 2001-06-12 | ザ ソールク インスチチュート フォア バイオロジカル スタディズ | Ｐｐａｒ―ガンマ活性化物質を使用する新生細胞増殖の結果である疾病状態の処置及びこの処置に有用な組成物 |
| US6387673B1 (en) | 1997-05-01 | 2002-05-14 | The Salk Institute For Biological Studies | Compounds useful for the modulation of processes mediated by nuclear hormone receptors, methods for the identification and use of such compounds |
-
1997
- 1997-08-28 ES ES97939631T patent/ES2196361T3/es not_active Expired - Lifetime
- 1997-08-28 CA CA002263817A patent/CA2263817A1/en not_active Abandoned
- 1997-08-28 US US08/919,318 patent/US6130230A/en not_active Expired - Lifetime
- 1997-08-28 IL IL12872397A patent/IL128723A0/xx unknown
- 1997-08-28 AU AU41674/97A patent/AU731060B2/en not_active Ceased
- 1997-08-28 EP EP97939631A patent/EP0928200B1/en not_active Expired - Lifetime
- 1997-08-28 DE DE69720745T patent/DE69720745T2/de not_active Expired - Fee Related
- 1997-08-28 WO PCT/US1997/015155 patent/WO1998008546A2/en not_active Ceased
- 1997-08-28 AT AT97939631T patent/ATE236654T1/de not_active IP Right Cessation
- 1997-08-28 JP JP10511906A patent/JP2001500486A/ja not_active Ceased
-
1999
- 1999-02-25 NO NO990912A patent/NO990912L/no not_active Application Discontinuation
-
2000
- 2000-07-19 US US09/619,308 patent/US6653322B1/en not_active Expired - Lifetime